ArticleScientific reports2025
SREBP-2 promotes cancer progression through the mevalonate-Akt pathway in non-small cell lung cancer.
Wenjie You et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it